Please try another search
For the three months ended 31 March 2016, HCP, Inc. revenues increased 5% to $640.8M. Net income applicable to common stockholders totaled $115.8M vs. loss of $240.9M. Revenues reflect Medical Office Buildings segment increase of 10% to $109M, FFO per Share (Basic) increase from -$0.26 to $0.68, FFO per Share (Diluted) increase from -$0.26 to $0.68. Net Income reflects Net Operating Income (NOI)-Sr. Housing increase of 14% to $178.5M.
Period Ending: | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 |
---|---|---|---|---|
Total Revenue | 607.53 | 610.79 | 603.53 | 596.64 |
Gross Profit | 471.19 | 478.76 | 473.1 | 497.04 |
Operating Income | 258.7 | -142.39 | 332.69 | 349.11 |
Net Income | 164.88 | -240.61 | 196.58 | 247.65 |
Period Ending: | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 |
---|---|---|---|---|
Total Assets | 22348.13 | 21024.44 | 21369.94 | 20744.89 |
Total Liabilities | 12115.34 | 10731.17 | 10634.64 | 9971.76 |
Total Equity | 10232.79 | 10293.27 | 10735.3 | 10773.12 |
Period Ending: | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 |
---|---|---|---|---|
Period Length: | 0 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | 230.07 | 1248.62 | 883.02 | |
Cash From Investing Activities | -328.29 | -1511.88 | -957.23 | |
Cash From Financing Activities | 51.72 | 144.8 | -142.82 | |
Net Change in Cash | -46.64 | -116.75 | -217.03 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review